Although several studies have reported a function for GSIs in GC treatment, they have been exclusive to investigating Notch signaling rather than the dysregulation of PS-1, the core subunit of γ-secretase, in the tumorigenesis of GC [23, 25, 26]. This evidence concerns the gene PSEN1 and gastric cancer.